the owner surrenders it by a written declaration to the IPI;
b.
the annual fees have not been paid in due time;
c.269 all authorisations of medicinal products containing the product are recalled (Art. 16a TPA270).
2 If all authorisations are suspended, the certificate is also suspended. Suspension does not interrupt the term of the certificate.271
3 The Swiss Agency for Therapeutic Products shall notify the IPI of any withdrawal or suspension of the authorisations.272